Inventor · Brookline, MA, US

Wayne I. Lencer

16Patents
6h-index
8Co-inventors
59Inventor score

Filing activity: Mar 20, 1996 → Aug 11, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US6485726B1 Receptor specific transepithelial transport of therapeutics Emerging Cross-Sectional Technologies 227 Expired
US6030613A Receptor specific transepithelial transport of therapeutics Chemistry; Metallurgy 205 Expired
US7067129B2 Receptor specific transepithelial transport in therapeutics Emerging Cross-Sectional Technologies 54 Expired
US7060274B2 Receptor specific transepithelial transport of therapeutics Emerging Cross-Sectional Technologies 51 Expired
US5889038A Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds Human Necessities 20 Expired
US6495567B1 Triaryl methane compounds and their use in the treatment of diarrhea and scours Human Necessities 18 Expired
US9457097B2 Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids Chemistry; Metallurgy 6 Active
US10806793B2 Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids Chemistry; Metallurgy 4 Active
US10765757B2 Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids Chemistry; Metallurgy 4 Active
US11559568B2 Short chain ceramide-based lipids and uses thereof Human Necessities 3 Active
US6291449A Use of 11-phenyl-dibenzazepine compounds to treat diarrhea or scours Human Necessities 2 Expired
US11771771B2 Ceramide-like lipid-based delivery vehicles and uses thereof Human Necessities 2 Active
US12383606B2 Short chain ceramide-based lipids and uses thereof Human Necessities 0 Active
US7547436B2 Receptor specific transepithelial transport of therapeutics Emerging Cross-Sectional Technologies 0 Active
US12296016B2 Ceramide-like lipid-based delivery vehicles and uses thereof Human Necessities 0 Active
US9072728B2 Treatment of severe distal colitis Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.